Kimberly Luckman
Adult Health · Lagrange, GANPI 1477197812
Payments from drug & device makers
Across 172 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Johnson & Johnson$518
- Merck$369
- Novartis$168
- Pfizer$140
- Cvrx, Inc.$102
- plus $876 from 21 others
What the payments were for
- Food & beverage$3,759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $1,587 |
| Johnson & Johnson | 46 | $518 |
| Merck | 21 | $369 |
| Novartis | 9 | $168 |
| Pfizer | 9 | $140 |
| Cvrx, Inc. | 5 | $102 |
| Amgen | 7 | $101 |
| Esperion Therapeutics, Inc. | 4 | $93 |
| Medicomp Inc | 5 | $91 |
| AbbVie | 5 | $89 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Scpharmaceuticals Inc. | 2 | $51 |
| Melinta Therapeutics, LLC | 2 | $48 |
| Boehringer Ingelheim | 2 | $41 |
| Novo Nordisk | 2 | $34 |
| GSK | 2 | $34 |
| Vital Connect, Inc | 1 | $30 |
| Veryan Medical Incorporated | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| Medtronic | 1 | $27 |
| Convatec Inc. | 1 | $27 |
| Abbott | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Biowound Solutions, Inc. | 3 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Reprise Biomedical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,759 in reported general payments places this provider in the 85th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $15,923 |
| Atorvastatin Calcium | 14 | $164 |
| ClopidogrelClopidogrel Bisulfate | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $140 | $15,92311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 577 adult health providers in Georgia.
Other adult health in Lagrange
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
- Jennifer SheldonMacon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.